Abstract:Objective To explore the predictive value of the systemic immune-inflammation index (SII) combined with microRNA-145 (miR-145) for pulmonary infections in patients undergoing radical surgery for lung cancer.Methods The study included 244 patients who underwent radical surgery for lung cancer at the Shaanxi Provincial People's Hospital from January 2020 to January 2023. The patients were divided into the infection group (n = 43) and the non-infection group (n = 201) based on the occurrence of pulmonary infection. Clinical data of patients were collected, and preoperative levels of inflammatory markers [C-reactive protein (CRP), interleukin-6 (IL-6) ], nutritional indicators (albumin, hemoglobin), and SII were compared between the two groups. The serum expression of miR-145 was measured using real-time quantitative polymerase chain reaction. The multivariable stepwise logistic regression model was applied to investigate the risk factors for pulmonary infection in patients undergoing radical surgery for lung cancer. The diagnostic efficacy of SII and miR-145 for pulmonary infection was assessed via receiver operating characteristic (ROC) curves.Results The infection group exhibited significantly higher prevalence of diabetes mellitus, higher smoking rate, older age, longer duration of surgery, and higher white blood cell count, inflammatory factor levels, and SII compared to the non-infection group (P < 0.05), while albumin levels and miR-145 expression were significantly lower in the infection group (P < 0.05). Multivariable stepwise logistic regression analysis revealed that advanced age [O^R = 1.520 (95% CI: 1.137, 2.031) ], prolonged surgical duration [O^R = 9.803 (95% CI: 1.865, 51.528) ], smoking [O^R = 118.515 (95% CI: 1.781, 7 884.700) ], diabetes mellitus [O^R = 133.243 (95% CI: 2.960, 5 997.049) ], low albumin [O^R = 0.525 (95% CI: 0.329, 0.836) ], elevated SII [O^R = 1.007 (95% CI: 1.002, 1.011) ], and low miR-145 levels [O^R = 0.011 (95% CI: 0.000, 0.675) ] were all risk factors for pulmonary infection in patients undergoing radical surgery for lung cancer (P < 0.05). The ROC curve analysis indicated that the combination of SII and miR-145 in predicting pulmonary infection in patients undergoing radical surgery for lung cancer yielded an area under the curve of 0.956 (95% CI: 0.927, 0.985), with a sensitivity of 81.4% (95% CI: 0.666, 0.916) and a specificity of 96.0% (95% CI: 0.923, 0.983).Conclusion Patients with higher SII and lower miR-145 expression are at increased risk of pulmonary infection, which may guide clinical assessment.